2014
DOI: 10.1093/carcin/bgu204
|View full text |Cite
|
Sign up to set email alerts
|

Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats

Abstract: 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is metabolized to enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), found in the urine of virtually all people exposed to tobacco products. We assessed the carcinogenicity in male F-344 rats of (R)-NNAL (5 ppm in drinking water), (S)-NNAL (5 ppm), NNK (5 ppm) and racemic NNAL (10 ppm) and analyzed DNA adduct formation in lung and pancreas of these rats after 10, 30, 50 and 70 weeks of treatment. All test compounds induced a high incidence … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
105
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 50 publications
(116 citation statements)
references
References 45 publications
10
105
0
1
Order By: Relevance
“…a-Hydroxylation occurs at either methylene or the methyl carbon adjacent to the N-nitroso group to generate unstable intermediates. These intermediates decompose to form electrophilic methyl-, pyridyloxobutyl-, and pyridylhydroxybutyldiazonium ions, which can attack DNA molecules, resulting in the formation of methyl-DNA and pyridyloxo(hydroxyl)butyl-DNA adducts (Balbo et al, 2014a;Chiang et al, 2011;Jalas et al, 2005). Inhibition of a-hydroxylation reduces the levels of these DNA adducts and of NNK-dependent tumor induction (Jalas et al, 2003;Staretz et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…a-Hydroxylation occurs at either methylene or the methyl carbon adjacent to the N-nitroso group to generate unstable intermediates. These intermediates decompose to form electrophilic methyl-, pyridyloxobutyl-, and pyridylhydroxybutyldiazonium ions, which can attack DNA molecules, resulting in the formation of methyl-DNA and pyridyloxo(hydroxyl)butyl-DNA adducts (Balbo et al, 2014a;Chiang et al, 2011;Jalas et al, 2005). Inhibition of a-hydroxylation reduces the levels of these DNA adducts and of NNK-dependent tumor induction (Jalas et al, 2003;Staretz et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…Some DNA adducts formed during NNK metabolism contribute to lung tumorigenesis (Balbo et al, 2014a). NNK metabolism mainly occurs via hydroxylation of one of the two a-carbons of the N-nitroso group by CYP2A6 and CYP2A13 (Chiang et al, 2011;Jalas et al, 2005), and leads to the formation of reactive intermediates that can form either DNA adducts (methyl DNA adducts and pyridyloxo(hydroxyl)butyl DNA adducts) or stable metabolites (e.g., 4-hydroxy-1-(3-pyridyl)-1-butanone and 4-oxo-1-(3-pyridyl)-1-butanone).…”
Section: Contents Lists Available At Sciencedirectmentioning
confidence: 99%
“…2 NNK is metabolized to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL, 2 , Figure 1), which is also a potent lung carcinogen with activity similar to NNK. 1,3,4 Both NNK and NNAL are metabolically activated by α-hydroxylation catalyzed by cytochrome P450s to form a series of intermediates which react with DNA to form adducts. The formation of these DNA adducts can cause miscoding and mutations in growth control genes, 57 which is a critical step in carcinogenesis by NNK and NNAL.…”
Section: Introductionmentioning
confidence: 99%
“…12 The major POB and PHB base adducts and B 1 p(POB)B 2 and B 1 p(PHB)B 2 phosphate adducts have been characterized, and their levels in NNK- and NNAL-treated animals have been quantified in our laboratory. 4,8,1014 α-Hydroxylation also occurs on the α-methylene carbons of NNK and NNAL, which produces intermediates α-methylenehydroxyNNK ( 4 ) and α-methylenehydroxyNNAL ( 5 ), respectively. Both 4 and 5 decompose to methane diazohydroxide ( 8 ), which reacts with DNA to form methyl DNA base adducts (Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…However the protective effect observed in PEP may occur through nicotine, a major toxic component of tobacco (see section on Nicotine), which activates the nicotinic anti-inflammatory pathway, and can reduce pancreatic inflammation (48,73,109,113). Nicotine can also relax the sphincter of Oddi in experimental models and might reduce sphincter spasm and obstruction which can cause PEP (12).…”
Section: Role Of Tobacco In Development Of Pancreatic Disease: Pancrementioning
confidence: 99%